11-17771838-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_001112741.2(KCNC1):​c.744C>T​(p.Ile248Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.04 in 1,614,160 control chromosomes in the GnomAD database, including 1,462 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. I248I) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.031 ( 120 hom., cov: 33)
Exomes 𝑓: 0.041 ( 1342 hom. )

Consequence

KCNC1
NM_001112741.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.320

Publications

4 publications found
Variant links:
Genes affected
KCNC1 (HGNC:6233): (potassium voltage-gated channel subfamily C member 1) This gene encodes a member of a family of integral membrane proteins that mediate the voltage-dependent potassium ion permeability of excitable membranes. Alternative splicing is thought to result in two transcript variants encoding isoforms that differ at their C-termini. These isoforms have had conflicting names in the literature: the longer isoform has been called both "b" and "alpha", while the shorter isoform has been called both "a" and "beta" (PMIDs 1432046, 12091563). [provided by RefSeq, Oct 2014]
KCNC1 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
  • progressive myoclonic epilepsy type 7
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P
  • progressive myoclonus epilepsy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 11-17771838-C-T is Benign according to our data. Variant chr11-17771838-C-T is described in ClinVar as Benign. ClinVar VariationId is 475360.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.32 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.062 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNC1NM_001112741.2 linkc.744C>T p.Ile248Ile synonymous_variant Exon 2 of 4 ENST00000265969.8 NP_001106212.1 P48547-2
KCNC1NM_004976.4 linkc.744C>T p.Ile248Ile synonymous_variant Exon 2 of 2 NP_004967.1 P48547-1
KCNC1XM_047426916.1 linkc.744C>T p.Ile248Ile synonymous_variant Exon 2 of 4 XP_047282872.1
KCNC1XR_930866.3 linkn.1966C>T non_coding_transcript_exon_variant Exon 2 of 3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNC1ENST00000265969.8 linkc.744C>T p.Ile248Ile synonymous_variant Exon 2 of 4 5 NM_001112741.2 ENSP00000265969.7 P48547-2

Frequencies

GnomAD3 genomes
AF:
0.0312
AC:
4746
AN:
152208
Hom.:
120
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00745
Gnomad AMI
AF:
0.0373
Gnomad AMR
AF:
0.0651
Gnomad ASJ
AF:
0.0176
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.00931
Gnomad FIN
AF:
0.0335
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0426
Gnomad OTH
AF:
0.0220
GnomAD2 exomes
AF:
0.0306
AC:
7698
AN:
251482
AF XY:
0.0290
show subpopulations
Gnomad AFR exome
AF:
0.00732
Gnomad AMR exome
AF:
0.0457
Gnomad ASJ exome
AF:
0.0194
Gnomad EAS exome
AF:
0.000598
Gnomad FIN exome
AF:
0.0287
Gnomad NFE exome
AF:
0.0410
Gnomad OTH exome
AF:
0.0311
GnomAD4 exome
AF:
0.0410
AC:
59892
AN:
1461834
Hom.:
1342
Cov.:
32
AF XY:
0.0400
AC XY:
29100
AN XY:
727204
show subpopulations
African (AFR)
AF:
0.00639
AC:
214
AN:
33480
American (AMR)
AF:
0.0478
AC:
2136
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0199
AC:
520
AN:
26136
East Asian (EAS)
AF:
0.000705
AC:
28
AN:
39696
South Asian (SAS)
AF:
0.0113
AC:
975
AN:
86258
European-Finnish (FIN)
AF:
0.0306
AC:
1633
AN:
53420
Middle Eastern (MID)
AF:
0.00329
AC:
19
AN:
5768
European-Non Finnish (NFE)
AF:
0.0472
AC:
52496
AN:
1111956
Other (OTH)
AF:
0.0310
AC:
1871
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
3629
7259
10888
14518
18147
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2018
4036
6054
8072
10090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0312
AC:
4751
AN:
152326
Hom.:
120
Cov.:
33
AF XY:
0.0316
AC XY:
2355
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.00743
AC:
309
AN:
41588
American (AMR)
AF:
0.0653
AC:
1000
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0176
AC:
61
AN:
3470
East Asian (EAS)
AF:
0.000579
AC:
3
AN:
5182
South Asian (SAS)
AF:
0.00952
AC:
46
AN:
4832
European-Finnish (FIN)
AF:
0.0335
AC:
356
AN:
10620
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0426
AC:
2894
AN:
68010
Other (OTH)
AF:
0.0218
AC:
46
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
232
464
695
927
1159
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0377
Hom.:
201
Bravo
AF:
0.0319
Asia WGS
AF:
0.00635
AC:
22
AN:
3478
EpiCase
AF:
0.0375
EpiControl
AF:
0.0362

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 06, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Feb 25, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

KCNC1-related disorder Benign:1
Apr 15, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Progressive myoclonic epilepsy type 7 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.43
CADD
Benign
6.8
DANN
Benign
0.87
PhyloP100
-0.32
PromoterAI
-0.012
Neutral
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2229007; hg19: chr11-17793385; COSMIC: COSV56395531; COSMIC: COSV56395531; API